CORRECTION article
Front. Mol. Biosci.
Sec. Cellular Biochemistry
Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1601841
Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats.
Provisionally accepted- 1Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
- 2Department of Basic Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia
- 3College of Science, Taibah University, Yanbu, Saudi Arabia
- 4Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia
- 5Faculty of Sciences, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia
- 6Department of Pathology, College of Medicine, Jouf University, Sakakah, Saudi Arabia
- 7Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
- 8King Saud University, Riyadh, Riyadh, Saudi Arabia
- 9Tanta University, Tanta, Egypt
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. • 1 Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Keywords: Avenanthramides, Antioxidants, anti-inflammatory, Doxorubicin, Hepatotoxicity, signaling pathway
Received: 28 Mar 2025; Accepted: 21 Apr 2025.
Copyright: © 2025 Alwaili, Abu-Almakarem, Aljohani, Alkhodair, Al-Bazi, Eid, Alamri, Mobasher, Algarzae, Ishaq A Khayyat, Alshaygy and El-Said. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Karim El-Said, Tanta University, Tanta, Egypt
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.